Santen Ventures

Corporate VC Active United States
Last updated 2026-06-18
Portfolio
2
in our dataset
Rounds participated
3
Rounds led
0
Rounds' value
$36.3M
total disclosed, rounds participated
Stages
—

Portfolio · 2

NovaSight
Eye-Tracking Based Solutions for Pediatric Vision Care
2 rounds $24.0M committed Latest: 2022-04
BELKIN Vision
One-second Laser Treatment for Glaucoma
1 round $12.3M committed Latest: 2020-07

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences2

Q&A

What is Santen Ventures' most recent exit?
Santen Ventures had an exit in July 2024 when BELKIN Vision was acquired by Alcon Pharmaceuticals for $81M.
What is Santen Ventures' primary sector focus?
Santen Ventures primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and exits falling within this category.
Which portfolio companies has Santen Ventures invested in?
Santen Ventures has invested in BELKIN Vision and NovaSight.
When did Santen Ventures make its most recent investment?
Santen Ventures made its most recent investment in April 2022.
What is the typical investment range for Santen Ventures?
Santen Ventures typically invests between $8M and $16M.
What kind of investor is Santen Ventures?
Santen Ventures is a corporate venture capital firm.
When was Santen Ventures founded?
Santen Ventures was founded in 2020.